diagnosi
rabi
routin
base
clinic
epidemiolog
inform
especi
exposur
report
rabiesendem
countri
diagnost
test
use
convent
assay
appear
neg
even
undertaken
late
diseas
despit
clinic
diagnosi
tendenc
time
unreli
test
rare
optim
entir
depend
natur
qualiti
sampl
suppli
cours
past
three
decad
applic
molecular
biolog
aid
develop
test
result
rapid
detect
rabi
viru
test
enabl
viral
strain
identif
clinic
specimen
current
number
molecular
test
use
complement
convent
test
rabi
diagnosi
inde
challeng
centuri
develop
rabi
diagnost
technic
natur
test
avail
challeng
centuri
diagnost
test
develop
twofold
firstli
achiev
intern
accept
valid
test
lead
accept
organis
global
secondli
area
world
test
need
mainli
develop
region
financi
logist
barrier
prevent
implement
although
develop
countri
poor
healthcar
infrastructur
recognis
molecularbas
diagnost
assay
unafford
routin
use
costbenefit
ratio
still
measur
adopt
rapid
afford
rabi
diagnost
test
use
develop
countri
highlight
import
share
transfer
technolog
laboratori
twin
develop
develop
countri
importantli
develop
countri
benefit
molecular
method
tool
capabl
differenti
diagnosi
human
diseas
present
similar
clinic
symptom
antemortem
test
human
rabi
possibl
use
molecular
techniqu
barrier
insurmount
expect
test
accept
implement
need
provid
substanti
improv
rabi
diagnosi
surveil
advent
molecular
biolog
new
technolog
initi
combin
advanc
biolog
disciplin
support
develop
techniqu
capabl
high
throughput
test
low
turnaround
time
rabi
diagnosi
valid
diagnost
test
confirm
presenc
rabi
viru
lyssaviru
variant
foundat
rabi
control
strategi
mani
countri
histor
histopatholog
techniqu
seller
stain
techniqu
use
determin
presenc
negri
bodi
rabi
virusspecif
antigen
howev
due
poor
sensit
specif
techniqu
longer
recommend
world
health
organ
fluoresc
antibodi
test
fat
reli
abil
detector
molecul
usual
fluorescein
isothiocyan
coupl
rabi
specif
antibodi
form
conjug
bind
allow
visualis
rabi
antigen
use
fluoresc
microscopi
techniqu
microscop
analysi
sampl
direct
method
allow
identif
rabi
virusspecif
antigen
short
time
reduc
cost
irrespect
geograph
origin
statu
host
regard
first
step
diagnost
procedur
laboratori
autolys
sampl
howev
reduc
sensit
specif
fat
rabi
tissu
cultur
infect
test
rtcit
mous
inocul
test
mit
base
propag
isol
viru
diagnost
test
use
detect
viru
particl
either
directli
tissu
sampl
fat
indirectli
anim
tissu
cultur
mit
rtcit
respect
rational
use
viru
isol
rtcitmit
sampl
suspicion
infect
rabi
viru
alway
recommend
especi
koch
postul
like
met
amplif
viral
pathogen
facilit
addit
molecular
analysi
undertaken
includ
sequenc
viral
isol
subsequ
phylogenet
analysi
convent
diagnost
test
rabi
fat
rtcit
mit
labour
intens
reli
upon
low
throughput
fat
complet
less
two
hour
contrast
rtcit
mit
requir
longer
turnaround
time
respect
fluoresc
antibodi
viru
neutralis
favn
test
rapid
fluoresc
focu
inhibit
test
rffit
utilis
similar
principl
measur
level
viru
neutralis
antibodi
vaccin
individu
indirect
serolog
method
includ
favn
rffit
measur
host
respons
infectionvaccin
detect
presenc
infecti
virusantigen
directli
howev
host
antibodi
detect
favnrffit
indirect
tool
measur
presenc
rabi
viru
nonimmunis
individu
evalu
host
respons
infect
test
may
lack
sensit
specif
interpret
test
result
may
difficult
host
respons
infect
vari
substanti
individu
neg
predict
valu
serolog
test
rabi
diagnosi
consid
poor
therefor
serolog
assay
suitabl
diagnost
tool
routin
rabi
test
intern
approv
method
provid
accur
time
inform
anim
human
rabi
case
therebi
support
surveil
rabi
provid
greater
understand
epidemiolog
diseas
box
numer
laboratori
rabiesendem
region
develop
world
cost
simplic
critic
factor
deliveri
diseas
diagnosi
neglect
even
princip
consider
rapid
diagnosi
therefor
cost
simplic
need
consid
new
technolog
adopt
region
world
need
molecular
tool
base
detect
manipul
genet
inform
viru
becom
wide
accept
access
diagnosi
rabi
advent
molecular
biolog
chang
face
diagnost
virolog
gener
enabl
high
throughput
short
turnaroundtim
analysi
sampl
st
centuri
expect
diagnost
virolog
techniqu
high
throughput
rabi
viru
detect
progress
rapidli
toward
use
molecular
diagnost
replac
convent
test
techniqu
viru
isol
histopatholog
also
possibl
immunolog
test
measur
surrog
marker
cytokin
electrolyt
augment
standard
diagnost
approach
nevertheless
continu
remain
odditi
outsid
realm
routin
diagnost
laboratori
confin
refer
laboratori
semiautom
autom
instrument
roboticsbas
techniqu
use
larg
number
test
undertaken
test
continu
increas
popular
use
especi
central
refer
laboratori
rather
local
region
facil
new
technolog
advanc
undoubtedli
faster
accur
may
time
offer
costeffect
altern
tradit
rabi
diagnost
test
paradigm
shift
includ
modern
advanc
technolog
lead
effect
control
rabi
anim
wildlif
box
review
provid
inform
latest
develop
diagnost
techniqu
determin
presenc
rabi
viru
nucleic
acid
diagnost
sampl
princip
focu
review
highlight
new
develop
virolog
relat
techniqu
diagnosi
surveil
rabi
literatur
review
identifi
web
scienc
pubm
scopu
use
variou
search
phrase
review
also
drew
inform
provid
intern
organis
mainli
oie
fund
uk
depart
environ
food
rural
affair
defra
advisori
context
diagnost
surveil
strategi
rabi
review
howev
reflect
view
defra
oie
review
provid
inform
latest
develop
diagnost
techniqu
determin
presenc
rabi
viru
diagnost
sampl
aim
provid
viewpoint
current
think
diagnost
virolog
rabi
reflect
neglect
natur
tropic
diseas
contrast
need
diagnost
laboratori
develop
develop
countri
develop
rapid
immunohistochem
test
drit
evalu
suspect
rabi
tissu
sampl
direct
rapid
immunohistochem
test
drit
postmortem
detect
rabi
viru
antigen
brain
smear
develop
use
cocktail
highli
concentr
purifi
biotinyl
monoclon
antibodi
rabi
antigen
detect
direct
stain
fresh
brain
impress
within
hour
test
employ
antirabi
monoclon
antibodi
specif
nucleoprotein
viral
protein
produc
abund
product
infect
fat
base
antibodi
specif
protein
conjug
fluorescein
isothiocyan
requir
fluoresc
microscop
visualis
specif
antibodi
bound
viral
protein
within
test
sampl
contrast
new
box
key
learn
point
drit
antibodi
cocktail
biotinyl
follow
short
incub
streptavidinperoxidas
complex
antibodyantigen
bind
complex
visualis
addit
substrat
perform
brain
tissu
drit
proven
sensit
fat
fresh
specimen
brain
impress
stain
use
drit
techniqu
read
within
one
hour
antibodi
cocktail
use
shown
detect
classic
rabi
viru
strain
genotyp
assess
current
fat
routin
use
detect
viru
antigen
badli
decompos
sampl
materi
purpos
test
sampl
develop
world
suitabl
cold
storag
sampl
often
unavail
factor
import
develop
new
test
obstacl
overcom
evalu
sampl
preserv
phosphat
buffer
glycerol
rang
temperatur
differ
time
period
prior
test
viru
antigen
glycerol
salin
solut
previous
recognis
suitabl
storag
media
tissu
sampl
absenc
cold
storag
box
use
drit
field
studi
tanzania
viral
antigen
could
detect
sampl
consider
time
period
post
collect
regardless
regimen
glycerol
preserv
use
applic
drit
analys
field
sampl
rabi
endem
region
also
proven
highli
success
field
trial
chad
sought
studi
drit
direct
comparison
fat
attempt
confirm
previou
studi
incid
rabi
within
district
known
endem
studi
result
two
test
agreement
issu
regard
use
drit
fat
need
drit
kit
store
refriger
prior
use
drit
enabl
develop
countri
perform
routin
rabi
surveil
greatli
reduc
cost
without
need
prohibit
expens
microscop
equip
along
expertis
financi
input
need
maintain
cost
effect
drit
allow
knowledg
technolog
transfer
area
develop
world
current
unabl
diagnos
rabi
case
anoth
method
detect
rabi
viru
antigen
postmortem
sampl
recent
develop
rapid
immunodiag
wwwplosntdsorg
nostic
test
ridt
base
principl
immunochromatographi
immunochromatograph
later
flow
strip
test
onestep
test
facilit
lowcost
rapid
identif
variou
analyt
includ
virus
briefli
suspect
materi
subject
test
devic
similar
later
flow
devic
conjug
detector
antibodi
attach
two
differ
zone
membran
indic
presenc
viral
antigen
preliminari
valid
studi
limit
number
sampl
show
ridt
might
great
potenti
use
method
rabi
diagnosi
without
need
laboratori
equip
howev
thorough
valid
includ
variou
circul
variant
rabv
lyssavirus
still
need
test
could
reli
upon
use
altern
gold
standard
fat
reversetranscriptas
polymeras
chain
reaction
rtpcr
variou
convent
rtpcr
protocol
diagnost
amplif
lyssaviru
genom
fragment
publish
tabl
sinc
primer
select
conserv
region
genom
assay
amplifi
part
nucleoprotein
n
gene
earlier
propos
gener
approach
intend
detect
lyssavirus
either
heminest
fulli
nest
amplif
use
applic
antemortem
saliva
csf
brain
postmortem
sampl
princip
brain
tissu
tabl
diagnost
procedur
also
appli
viru
character
includ
sequenc
reaction
restrict
fragment
length
polymorph
rflp
also
strainspecif
rtpcr
develop
distinguish
variou
rabi
viru
rabv
strain
particular
region
classic
rtpcr
assay
prove
sensit
specif
tool
routin
diagnost
purpos
particularli
decompos
sampl
archiv
specimen
sole
detect
amplifi
rtpcr
product
gelbas
system
howev
especi
use
heminest
rtpcr
gener
risk
crosscontamin
allow
exact
quantif
genom
copi
includ
test
specif
hybridis
method
pcrelisa
method
establish
overcom
difficulti
although
techniqu
becom
univers
accept
addit
mani
laboratori
use
partial
sequenc
confirm
detect
lyssaviru
obtain
data
use
phylogenet
analysi
virus
circul
specif
region
import
sequenc
pcr
product
highlight
experiment
studi
studi
demonstr
although
nest
rtpcr
shown
sensit
diagnost
techniqu
employ
host
genom
amplicon
size
target
amplicon
observ
agaros
gel
subsequ
confirm
fals
posit
follow
direct
sequenc
introduct
fluorogen
probe
detect
sequenc
specif
templat
achiev
realtim
specif
ensur
inher
hybrid
reaction
crosscontamin
avoid
due
close
tube
natur
test
consequ
rabv
lyssavirus
variou
pcr
assay
use
taqman
technolog
describ
tabl
gener
realtim
taqmanpcr
detect
differenti
lyssaviru
genotyp
also
develop
assay
utilis
panlyssaviru
primer
set
shown
amplifi
larg
panel
repres
lyssavirus
probe
specif
design
discrimin
classic
rabi
viru
european
bat
lyssavirus
pcr
assay
use
taqman
technolog
applic
antemortem
postmortem
sampl
panlyssaviru
primer
wwwplosntdsorg
set
also
use
conjunct
specif
dye
sybr
green
allow
rapid
detect
amplicon
valid
probe
base
assay
reli
avail
repres
virus
nucleic
acid
howev
lyssaviru
genotyp
limit
number
virus
sequenc
avail
primerprob
design
may
repres
genet
divers
current
variant
circul
singl
mutat
north
american
rabv
strain
region
primer
probe
alter
sensit
pcr
thu
genet
divers
among
lyssavirus
may
hamper
use
singl
assay
lyssavirus
scan
surveil
may
benefit
use
panlyssaviru
primer
sybr
green
assay
rather
strain
specif
base
assay
use
rapid
autom
nasba
techniqu
success
appli
antemortem
saliva
cerebrospin
fluid
csf
four
rabi
patient
thailand
shown
tenfold
increas
sensit
compar
rtpcr
assay
detect
rabi
viral
rna
earli
two
day
onset
symptom
nasba
techniqu
involv
use
three
enzym
revers
transcriptas
rnase
h
rna
polymeras
synthesis
multipl
copi
target
rna
isotherm
condit
briefli
larg
number
rna
copi
gener
use
pair
specif
primer
one
contain
rna
polymeras
bind
site
electrochemiluminesc
detect
region
attach
end
tabl
convent
gelbas
pcrassay
detect
lyssaviru
speci
rabv
wwwplosntdsorg
amplifi
rna
detect
use
autom
reader
enabl
rapid
throughput
test
rel
easi
use
whole
process
extract
detect
take
littl
four
hour
technolog
alreadi
appli
point
care
test
bacteri
pathogen
viral
pathogen
nasba
techniqu
also
adapt
investig
rabi
viru
replic
situ
wherebi
rel
lower
isotherm
temperatur
nasba
compar
insitu
rtpcr
ensur
cell
integr
maintain
lamp
offer
altern
dna
amplif
method
polymeras
chain
reaction
applic
antemortem
saliva
csf
test
origin
techniqu
suggest
amplifi
high
specif
effici
without
need
thermal
cycl
amplif
achiev
specif
bind
two
inner
two
outer
primer
target
sequenc
inner
primer
initi
strand
synthesi
whilst
outer
primer
displac
inner
primer
allow
selfann
nascent
strand
creat
hairpin
structur
trigger
strand
synthesi
turn
lead
concaten
target
sequenc
polymeris
strand
displac
achiev
use
singl
enzym
bst
dna
polymeras
techniqu
rapid
gener
larg
quantiti
target
sequenc
within
minut
amplif
rna
virus
revers
transcript
step
undertaken
prior
lamp
reaction
primer
set
success
develop
detect
rang
pathogen
virus
includ
west
nile
viru
japanes
enceph
viru
foot
mouth
diseas
viru
chikungunya
viru
assess
applic
lamp
detect
rabi
viru
design
primer
set
use
primerexplor
softwar
eiken
chemic
compani
ltd
japan
detect
challeng
viru
standard
cv
fix
strain
rabi
viru
tabl
addit
standard
set
four
primer
two
loopbind
primer
ad
increas
rate
strand
displac
synthesi
revers
transcript
lamp
reaction
undertaken
simultan
rtlamp
singl
tube
use
wwwplosntdsorg
thermost
revers
transcriptas
henc
avoid
step
process
inher
rtpcr
target
amplif
monitor
incorpor
doubl
strand
dna
bind
fluorophor
picogreen
figur
separ
agaros
gel
figur
constant
temperatur
cv
rna
could
detect
within
minut
develop
rtlamp
assay
use
diagnosi
surveil
challeng
consider
sequenc
variat
observ
within
rabi
viru
genom
frustrat
specif
primer
design
preliminari
attempt
suggest
multipl
combin
primer
differ
primer
lead
sensit
rapid
amplif
rabv
genom
wide
rang
geograph
locat
use
isotherm
amplif
benefit
reduc
technolog
requir
thermal
cycl
use
rtpcr
turn
offer
opportun
link
later
flow
devic
develop
surveil
protocol
test
take
place
field
less
sophist
laboratori
microarray
link
sequenc
independ
pcr
amplif
offer
abil
rapidli
identifi
pathogen
virus
postmortem
sampl
undertaken
studi
demonstr
abil
microarray
detect
seven
lyssaviru
genotyp
vla
weybridg
unpublish
data
microarray
compos
oligonucleotid
probe
nucleotid
length
includ
probe
set
seven
classifi
genotyp
set
unclassifi
lyssavirus
wwwplosntdsorg
diagnost
capabl
array
illustr
show
abil
array
detect
rabv
human
case
rabi
amplifi
rna
bound
specif
classic
rabi
viru
genotyp
probe
set
figur
develop
novel
ultrasensit
stabl
potentiometr
immunosensor
stabl
potentiometr
immunosensor
detect
variou
analyt
interest
complex
real
world
sampl
blood
serum
milk
describ
biosensor
detect
enzym
label
immunocomplex
form
surfac
polypyrrol
coat
screenprint
gold
silver
electrod
detect
secondari
reaction
produc
charg
product
shift
potenti
measur
local
chang
redox
state
ph
andor
ionic
strength
magnitud
chang
potenti
directli
relat
level
target
matrix
assay
quantit
numer
output
rapidli
transmiss
bioassay
produc
rapid
result
minut
highli
reproduc
ultrasensit
fm
thu
sort
biosensor
offer
rapid
product
signal
later
flow
devic
sensit
third
gener
elisa
immunoassay
develop
sandwich
competit
format
small
eg
digoxin
mw
da
larg
eg
hepat
b
surfac
antigen
kda
molecul
addit
immunoassay
also
possibl
detect
specif
nucleic
acid
whole
cell
use
technolog
due
method
product
electrod
strip
base
assay
inexpens
us
per
strip
detect
hardwar
us
addit
immunoassay
readili
adapt
format
minim
addit
optimis
potentiometr
immunosensor
detect
rabi
viru
nucleoprotein
progress
offer
abil
rapidli
screen
complex
nonclarifi
matric
possibl
pensid
costeffect
manner
serolog
assay
suitabl
diagnost
tool
routin
rabi
test
host
respons
infect
vari
substanti
individu
howev
serolog
still
use
particularli
monitor
develop
immun
respons
would
suggest
detect
rabi
antibodi
serum
csf
earli
present
absenc
histori
vaccin
may
posit
indic
therapeut
intervent
viral
pseudotyp
core
one
viru
coat
envelop
protein
deriv
second
viru
offer
safe
altern
use
pathogen
virus
neutralis
assay
use
pseudotyp
express
genotyp
glycoprotein
high
titr
stock
infecti
unitsml
produc
prove
specif
highli
sensit
compar
neutralis
titr
achiev
use
favn
high
correl
also
observ
r
use
pseudotyp
express
genotyp
genotyp
gprotein
neutralis
antibodi
titr
broadli
correl
degre
gprotein
divers
vaccin
studi
tanzania
compar
two
assay
pseudotyp
show
specif
sensit
favn
high
correl
antibodi
titr
r
incorpor
lago
bat
viru
genotyp
mokola
viru
genotyp
duvenhag
viru
genotyp
gprotein
well
lacz
report
gene
make
pseudotyp
assay
attract
option
serosurveil
africa
resourc
limit
countri
addit
pseudotyp
assay
use
substanti
less
input
serum
ml
compar
favn
rffit
multipl
test
undertaken
sampl
collect
volum
limit
valuabl
eg
bat
sera
due
neurotrop
natur
rabi
viru
infect
result
enorm
viral
replic
cn
final
stage
diseas
lead
massiv
antigen
viral
genom
concentr
make
detect
viral
antigen
brain
tissu
test
fat
drit
robust
rel
simpl
perform
becom
rapid
gold
standard
test
detect
viral
genom
approach
avail
process
multipl
specimen
nucleic
acid
extract
genet
type
significantli
reduc
risk
contamin
addit
use
taqman
rtpcr
similar
technolog
robot
platform
allow
rapid
largescal
rabi
detect
type
quantif
real
time
develop
pcrbase
method
box
provid
altern
method
post
mortem
rabi
diagnosi
possibl
ant
mortem
diagnosi
human
rabi
rtpcr
method
invari
involv
multipl
transfer
nucleic
acid
differ
tube
coupl
high
sensit
pcr
methodolog
small
amount
contam
figur
amplif
rabi
viru
rna
revers
transcript
loopmedi
isotherm
amplif
rtlamp
reaction
mg
rna
prepar
use
trizol
invitrogen
normal
mous
brain
circl
infect
mous
brain
triangl
ad
reaction
mixtur
contain
six
primer
concentr
indic
tabl
inat
undoubtedli
produc
falseposit
result
attempt
made
adapt
rtpcr
reduc
manipul
therebi
reduc
contamin
risk
visualis
pcr
product
gel
electrophoresi
expos
facil
oper
larg
quantiti
amplifi
materi
thu
mani
adapt
direct
replac
step
new
improv
rapid
diagnost
tool
rabi
use
taqman
technolog
develop
avoid
crosscontamin
due
close
tube
natur
test
benefit
rtpcr
enabl
practic
molecular
character
rabi
virus
ad
significantli
understand
viru
evolut
epidemiolog
approach
supersed
use
monoclon
antibodi
type
characteris
new
strain
rabi
viru
provid
evid
support
delin
lyssavirus
genotyp
box
use
classif
anoth
four
put
member
genu
also
techniqu
prerequisit
understand
molecular
biolog
lyssavirus
underpin
futur
develop
rabi
diagnosi
prevent
like
futur
microarray
techniqu
combin
sophist
bioinformat
array
hierarch
set
probe
provid
altern
rapid
viru
discoveri
characteris
develop
realtim
rtpcr
techniqu
allow
quantif
rna
realtim
give
rel
quick
reliabl
method
measur
level
viral
rna
pcr
base
techniqu
current
recommend
routin
postmortem
diagnosi
rabi
howev
laboratori
strict
qualiti
control
procedur
place
demonstr
experi
expertis
molecular
techniqu
success
appli
confirmatori
diagnosi
epidemiolog
survey
reason
like
intern
bodi
accept
use
futur
routin
rabi
diagnosi
revers
transcript
pcr
report
confirm
rabi
diagnosi
intravitam
suspect
human
case
convent
diagnost
method
fail
postmortem
materi
avail
box
rabi
viru
rna
detect
rang
biolog
fluid
sampl
eg
saliva
csf
tear
skin
biopsi
sampl
urin
owe
intermitt
shed
viru
serial
sampl
fluid
saliva
urin
test
neg
result
use
exclud
diagnosi
rabi
posit
pcr
result
sequenc
confirm
origin
viru
rule
possibl
contamin
term
rna
concentr
brain
sensit
especi
nest
realtim
pcr
may
beyond
threshold
need
routin
postmortem
test
also
contamin
neg
sampl
could
lead
unjustifi
administr
high
number
costli
post
exposur
prophylaxi
would
produc
fals
data
rabi
surveil
howev
introduct
accredit
laboratori
qualiti
control
measur
implement
grow
number
laboratori
worldwid
qualiti
control
diagnost
rabi
pcr
encompass
sever
measur
includ
inclus
appropri
posit
neg
inhibit
control
assay
run
consist
interassay
reproduc
also
ensur
time
monitor
perform
laboratori
meet
requir
standard
pcr
fulfil
full
potenti
use
pcr
restrict
confirmatori
diagnost
test
decompos
sampl
also
power
tool
viru
type
figur
microarray
identif
rabi
viru
rna
prepar
brain
sampl
confirm
case
human
rabi
total
rna
extract
use
trizol
invitrogen
treat
dnase
prior
convers
doubl
strand
dna
nonspecif
amplif
achiev
use
dna
polymeras
klen
taq
sigma
product
label
bind
alexa
fluor
reactiv
dye
invitrogen
amplicon
label
target
dna
denatur
chill
ice
dilut
hybrid
buffer
addit
microarray
slide
hybrid
occur
overnight
slide
wash
targetprob
bind
captur
use
genepix
pro
softwar
molecular
devic
statist
analysi
data
conduct
use
detectiv
softwar
molecular
epidemiolog
studi
lack
standard
major
obstacl
gener
use
pcr
rabi
diagnosi
especi
develop
countri
evid
rtpcr
domin
genet
detect
rabi
viru
seem
probabl
techniqu
domin
rabi
diagnosi
st
centuri
howev
discount
altern
benefit
isotherm
amplif
enabl
implement
laboratori
access
thermal
cycler
obstacl
nasba
techniqu
success
appli
saliva
csf
four
live
patient
rabi
detect
rabi
viral
rna
onset
symptom
techniqu
also
adapt
investig
rabi
viru
replic
insitu
lamp
also
fall
categori
adapt
use
later
flow
devic
thu
make
applic
simpl
exist
assay
rabi
viru
antibodi
preval
studi
either
requir
high
contain
facil
distinguish
neutralis
nonneutralis
antibodi
recent
howev
neutralis
assay
use
retrovir
pseudotyp
describ
bound
restrict
list
also
allow
choic
endpoint
report
protein
bgalactosidas
green
fluoresc
protein
luciferas
benefit
techniqu
adapt
use
small
volum
sera
thu
make
use
surveil
current
highthroughput
rabi
viru
molecular
detect
method
augment
standard
diagnost
test
process
develop
refin
use
alon
progress
st
centuri
possibl
techniqu
replac
convent
test
box
obstacl
adopt
includ
cost
complex
local
accept
use
also
possibl
immunolog
test
measur
indirect
marker
cytokin
electrolyt
increas
use
test
howev
probabl
remain
realm
larg
refer
laboratori
resourc
allow
develop
novel
assay
far
semiautom
autom
instrument
roboticsbas
techniqu
concern
use
larg
number
test
undertaken
surveil
companion
anim
test
test
continu
increas
popular
use
especi
central
refer
facil
clear
need
simplifi
molecular
diagnost
techniqu
test
appli
univers
develop
develop
countri
like
new
develop
focu
gener
low
volum
yet
afford
diagnost
test
rabi
use
made
pointofcar
poc
diagnost
test
use
portabl
extract
techniqu
link
pcr
machin
use
lyophilis
reagent
overcom
coldchain
depend
tropic
countri
st
centuri
technolog
demonstr
impact
peopl
live
develop
countri
especi
rabi
still
consid
neglect
diseas
contrast
develop
world
new
technolog
advanc
undoubtedli
faster
accur
costeffect
lead
theragnost
approach
combin
therapeut
diagnost
human
treatment
rabi
interest
treat
human
rabi
aggress
gain
momentum
larg
due
report
success
treat
girl
clinic
rabi
develop
one
month
bitten
bat
use
combin
therapeut
coma
antivir
drug
whilst
allow
host
immun
system
confer
immun
milwauke
protocol
box
bioinformat
genom
proteom
function
genom
molecular
biolog
tool
essenti
progress
molecular
theragnost
earli
diagnosi
monitor
serolog
critic
factor
success
treatment
rabi
patient
addit
theragnost
could
elimin
unnecessari
treatment
patient
rabi
immunotherapi
appropri
ie
immunosuppress
patient
result
substanti
drug
cost
save
healthcar
system
